| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00042737-200207000-00006 |
| P698 | PubMed publication ID | 12169983 |
| P50 | author | Jan Wehkamp | Q42715392 |
| P2093 | author name string | Eduard F Stange | |
| Klaus Fellermann | |||
| Alfred C Feller | |||
| Charlotte Wohlschläger | |||
| Klaus R Herrlinger | |||
| Klaus Schmidt | |||
| Michael Duchrow | |||
| Bettina Schwind | |||
| Steffi Baxmann | |||
| P433 | issue | 7 | |
| P921 | main subject | inflammatory bowel diseases | Q917447 |
| P304 | page(s) | 745-752 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | European Journal of Gastroenterology and Hepatology | Q15746143 |
| P1476 | title | Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease | |
| P478 | volume | 14 |
| Q95507507 | Q95507507 |
| Q42409990 | Activated innate immune system in irritable bowel syndrome? |
| Q36778895 | An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease |
| Q38040831 | Antimicrobial peptides and colitis |
| Q41477282 | Antimicrobial peptides in gastrointestinal inflammation |
| Q36875869 | Antimicrobial peptides: natural effectors of the innate immune system |
| Q27023239 | Antimicrobial proteins in intestine and inflammatory bowel diseases |
| Q37349793 | Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease |
| Q90160053 | Beneficial effect of immunobiotic strains on attenuation of Salmonella induced inflammatory response in human intestinal epithelial cells |
| Q28583123 | CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells |
| Q33270568 | Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation |
| Q33866970 | Contribution of genetics to a new vision in the understanding of inflammatory bowel disease. |
| Q37276947 | Crohn's disease--defect in innate defence. |
| Q34511701 | Cyclooxygenase-2 Enhances Antimicrobial Peptide Expression and Killing of Staphylococcus aureus |
| Q22242645 | Defects in mucosal immunity leading to Crohn's disease |
| Q42161372 | Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. |
| Q39904972 | Defensin-immunology in inflammatory bowel disease |
| Q35923523 | Distinct elevation of levels of anti-Caenorhabditis elegans antibody in sera of patients with inflammatory bowel disease |
| Q37780272 | Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity |
| Q35596103 | Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis |
| Q33735990 | Expression of human beta-defensins in children with chronic inflammatory bowel disease |
| Q36888459 | FAD-I, a Fusobacterium nucleatum Cell Wall-Associated Diacylated Lipoprotein That Mediates Human Beta Defensin 2 Induction through Toll-Like Receptor-1/2 (TLR-1/2) and TLR-2/6. |
| Q51604294 | Fecal Human β-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response? |
| Q33694183 | Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation |
| Q91899425 | High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures |
| Q58701247 | Histone deacetylase-mediated regulation of the antimicrobial peptide hBD2 differs in intestinal cell lines and cultured tissue |
| Q37123995 | Human β-defensin 2 induces extracellular accumulation of adenosine in Escherichia coli |
| Q37602033 | IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide |
| Q38423061 | IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease |
| Q36125752 | Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease |
| Q34036608 | Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review |
| Q34312402 | Inflammatory bowel disease: an impaired barrier disease |
| Q37608109 | Inflammatory bowel disease: review from the aspect of genetics |
| Q27023724 | Intestinal barrier in inflammatory bowel disease |
| Q36304262 | Mechanisms of disease: defensins in gastrointestinal diseases |
| Q38781325 | Microbiome and chronic inflammatory bowel diseases |
| Q36273576 | Microgeographic Proteomic Networks of the Human Colonic Mucosa and Their Association With Inflammatory Bowel Disease |
| Q40017434 | NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. |
| Q30497993 | NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis |
| Q41917631 | NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression |
| Q42105434 | NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease |
| Q92668932 | Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease |
| Q35954105 | Reduced mucosal antimicrobial activity in Crohn's disease of the colon |
| Q35563983 | Regulation of expression of β-defensins: endogenous enteric peptide antibiotics |
| Q26776055 | Regulation of the Intestinal Barrier Function by Host Defense Peptides |
| Q36216430 | Specific-sized hyaluronan fragments promote expression of human β-defensin 2 in intestinal epithelium |
| Q37633135 | The Interplay between Defensins and Microbiota in Crohn's Disease |
| Q45796015 | The dietary histone deacetylase inhibitor sulforaphane induces human beta-defensin-2 in intestinal epithelial cells |
| Q34647328 | The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota |
| Q37945181 | Therapeutic approaches using host defence peptides to tackle herpes virus infections |
| Q80373625 | beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis |
| Q39168125 | β-Defensins in the Fight against Helicobacter pylori. |
Search more.